n-acetylglucosaminono-1,5-lactone o-(phenylcarbamoyl)oxime and Mucopolysaccharidosis III

n-acetylglucosaminono-1,5-lactone o-(phenylcarbamoyl)oxime has been researched along with Mucopolysaccharidosis III in 1 studies

*Mucopolysaccharidosis III: Mucopolysaccharidosis characterized by heparitin sulfate in the urine, progressive mental retardation, mild dwarfism, and other skeletal disorders. There are four clinically indistinguishable but biochemically distinct forms, each due to a deficiency of a different enzyme. [MeSH]

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Boraston, AB; Ficko-Blean, E; Nemirovsky, O; Stubbs, KA; Vocadlo, DJ	1

Other Studies

1 other study(ies) available for n-acetylglucosaminono-1,5-lactone o-(phenylcarbamoyl)oxime and Mucopolysaccharidosis III

Article	Year
Structural and mechanistic insight into the basis of mucopolysaccharidosis IIIB. Proceedings of the National Academy of Sciences of the United States of America, 2008, May-06, Volume: 105, Issue:18 Topics: Acetylglucosaminidase; Bacterial Proteins; Binding Sites; Catalysis; Clostridium perfringens; Drug Design; Glycoside Hydrolases; Humans; Models, Molecular; Molecular Chaperones; Mucopolysaccharidosis III; Mutation; Protein Structure, Secondary	2008

Article

Year

Structural and mechanistic insight into the basis of mucopolysaccharidosis IIIB.

Proceedings of the National Academy of Sciences of the United States of America, 2008, May-06, Volume: 105, Issue:18

Topics: Acetylglucosaminidase; Bacterial Proteins; Binding Sites; Catalysis; Clostridium perfringens; Drug Design; Glycoside Hydrolases; Humans; Models, Molecular; Molecular Chaperones; Mucopolysaccharidosis III; Mutation; Protein Structure, Secondary

2008